Ontarians can get their vaccines right away on one of the GO-VAXX mobile COVID-19 vaccine clinics which are accepting walk-ins as well as appointments.
There are now six GO-VAXX buses on the road, with another two set to join the fleet by the end of February.
The GO-VAXX buses are fully accessible and heated. Each bus can administer up to 300 doses of the Pfizer vaccine per day.
The buses have administered more than 42,000 doses at over 440 clinics since they debuted last August, and have visited communities across 24 of Ontario’s public health units, ranging from Windsor-Essex in the west, Haliburton in the north, and Ottawa in the east.
“The GO-VAXX buses make it as easy and convenient as possible to get vaccinated by taking vaccines to where people are going about their daily lives, from shopping malls to cultural communities, festivals and sporting events to congregate care settings like retirement homes,” said Solicitor General Sylvia Jones. “The buses have played an integral role in our efforts to accelerate the booster shot distribution, as well as continuing to deliver first, second and paediatric doses.”
The GO-VAXX mobile vaccine clinics are a partnership between Metrolinx, local public health units and the province. They are a key part of Ontario’s last mile strategy, which focuses on community-based and easy-to-access settings for vaccinations. The province is working with public health units to target areas with low vaccination rates to support localized vaccination strategies.
Check the GO-VAXX schedule for times and locations.
To book an appointment at a GO-VAXX mobile vaccine clinic, visit the COVID-19 vaccination portal or call the Provincial Vaccine Contact Centre at 1-833-943-3900.
As of February 6, the province has administered more than 31 million doses of the COVID-19 vaccine, with 92.1 per cent of Ontarians aged 12 and over having received at least one dose and 89.5 per cent having received a second dose. 54.4 per cent of children aged five to 11 have received their first dose, and 23.8 per cent have received their second dose. 44.8 per cent of individuals aged 18 and over have received their booster dose.